Domzalski David Insider Trades

Insider Trading History

Track insider trading activity for Domzalski David. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
VYNE Therapeutics
VYNE Therapeutics VYNE
PRESIDENT AND CEO
Holding Value $264k 401,976 shares
Last Trade
Mar 31, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$8.54k 14,232 shares
$0.60
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
PRESIDENT AND CEO
Holding Value $273k 416,208 shares
Last Trade
Dec 31, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$7.36k 12,684 shares
$0.58
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
PRESIDENT AND CEO
Holding Value $281k 428,892 shares
Last Trade
Sep 30, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.31k 12,676 shares
$0.34
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
PRESIDENT AND CEO
Holding Value $290k 441,568 shares
Last Trade
Jun 30, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$20.9k 12,676 shares
$1.65
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
PRESIDENT AND CEO
Holding Value $298k 454,244 shares
Last Trade
Jun 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.06k 8,681 shares
$0.93
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
PRESIDENT AND CEO
Holding Value $292k 445,563 shares
Last Trade
Mar 31, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$48.2k 30,498 shares
$1.58
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
PRESIDENT AND CEO
Holding Value $479k 730,000 shares
Last Trade
Jan 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.02M 730,000 shares
$2.77
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
PRESIDENT AND CEO
Holding Value $312k 476,061 shares
Last Trade
Dec 31, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$82.2k 24,536 shares
$3.35
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
PRESIDENT AND CEO
Holding Value $328k 500,597 shares
Last Trade
Nov 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.5k 3,901 shares
$2.96
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
PRESIDENT AND CEO
Holding Value $326k 496,696 shares
Last Trade
Sep 30, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.29k 685 shares
$1.88
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
PRESIDENT AND CEO
Holding Value $326k 497,654 shares
Last Trade
Jul 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.8k 935 shares
$1.92
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
PRESIDENT AND CEO
Holding Value $327k 498,589 shares
Last Trade
May 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.2k 4,429 shares
$2.54
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
PRESIDENT AND CEO
Holding Value $324k 494,160 shares
Last Trade
Apr 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.09k 1,004 shares
$3.08
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
President And CEO
Holding Value $325k 495,164 shares
Last Trade
Jan 02, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.29k 1,004 shares
$2.28
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
President And CEO
Holding Value $325k 496,168 shares
Last Trade
Jan 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.05M 450,000 shares
$2.33
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
President And CEO
Holding Value $178k 271,168 shares
Last Trade
Dec 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.22M 450,000 shares
$2.70
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
President And CEO
Holding Value $30.3k 46,168 shares
Last Trade
Nov 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.56k 2,284 shares
$3.31
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
President And CEO
Holding Value $28.8k 43,884 shares
Last Trade
Oct 02, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$32.7k 8,549 shares
$3.83
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
President And CEO
Holding Value $34.4k 52,433 shares
Last Trade
Jun 30, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.02k 981 shares
$4.10
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
President And CEO
Holding Value $35k 53,414 shares
Last Trade
May 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.4k 2,766 shares
$6.29
$0.66

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up